Overview
McDermott intellectual property litigation lawyers, who with lawyers from two other firms secured for client Amgen a jury verdict of infringement and a permanent injunction against the sale of the infringing anti-cholesterol drug, continue to represent the company as the Federal Circuit stayed the injunction pending consideration of an appeal.